Biggest News Aggregation in the World
📰 Ci 210 News

Ci 210 News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ci 210. Real-time updates on events, politics, business and more.

SciSparc Shares Rise On Initiating Clinical Trial Of SCI-210

SciSparc Ltd. (SPRC) shares surged by 51% on Friday following the announcement of the initiation of a clinical trial at Soroka Medical Center in Israel. The trial will be conducted using the company's proprietary therapy, SCI-210, which is aimed at easing the symptoms of autism spectrum disorder (ASD) in children.
Oz Adler Soroka Medical Center Scisparc Ltd National Autism Research Center Chief Executive Officer Ci 210

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science